The Journal

Clinical insights
for the optimized human.

Deep dives into peer-reviewed literature, peptide mechanisms, and structural protocols. No fluff, just science.

The Phase 3 Trial Data on Retatrutide: What the 24% Mean Loss Actually Means

A comprehensive breakdown of the latest clinical outcomes surrounding triple-agonists and what they mean for the future of metabolic therapy.

Understanding the biological mechanisms of aging, and how specific peptide protocols are targeting senescent cells for systemic renewal.

Which compound to choose, when to blend them, and the underlying pathways they use to accelerate tissue and tendon remodeling.

How to structure training, nutrition, and supplemental peptide protocols to prevent muscle catabolism during aggressive fat loss phases.

Exploring the compounds designed to enhance brain-derived neurotrophic factor (BDNF) and repair neuro-inflammation.

The science of deep sleep recovery, circadian rhythm realignment, and how specific peptide pathways encourage optimal REM cycles.